Adderall is the brand name for mixed amphetamine salts, a Schedule II controlled substance used primarily to treat ADHD (attention-deficit/hyperactivity disorder) and narcolepsy. The drug contains four amphetamine salt compounds: amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate in a 3:1 dextro-to-levo ratio. Generic versions became available after the brand patent expired and are manufactured by multiple companies.
The ongoing shortage began in October 2022 when Adderall manufacturer Teva reported supply disruptions. By 2026, both the FDA and the American Society of Health-System Pharmacists (ASHP) still list mixed amphetamine salts IR and XR as in shortage. The DEA increased production quotas by 25% in late 2025, which has improved conditions for some strengths. Doses of 15 mg, 20 mg, 25 mg, and 30 mg remain intermittently unavailable at pharmacies nationwide, forcing some patients to call multiple pharmacies before finding their prescribed strength. Patients managing costs while dealing with the shortage can also check Medicaid income limits to see whether they qualify for near-zero copays.
Because Adderall is an oral, self-administered drug dispensed at retail pharmacies, it is billed exclusively through Medicare Part D (not Part B). There is no Medicare ASP rate for Adderall and no HCPCS J-code applies. Patients pay under their Part D plan's formulary tier system, subject to the 2026 annual out-of-pocket cap of $2,100. Most Part D plans cover generic amphetamine salts, often on Tier 2, but prior authorization is common and some plans restrict quantity. To review your Medicare coverage options, see the Medicare eligibility guide.
What Adderall Costs by Point of Pay (2026)
The price you pay depends almost entirely on WHERE you pay. The same adderall can cost many times more at a hospital than at your local pharmacy:
2026 Adderall Price by Point of Pay| Where you pay | Typical cost | Notes |
|---|
| Pharmacy counter (retail, no insurance) | $30 - $300 / 30-day supply | Generic IR: $30-$100. Generic XR: $50-$300. Brand XR list price: ~$415 |
| Pharmacy counter (GoodRx coupon) | $17 - $45 / 30-day supply | Coupon prices vary by pharmacy and dose |
| Medicare Part D (2026) | $0 - $50 / 30-day supply (plan-dependent) | Subject to $2,100 annual OOP cap; prior authorization common |
| Inpatient hospital (if administered during stay) | $50 - $400 billed per course | Marked up at facility rate; rarely the primary billing concern for ADHD patients |
| Medicaid | $1 - $4 / prescription | Covered in all 50 states; PA requirements apply in most states |
Retail prices vary by dose strength and formulation. GoodRx coupon prices are as of May 2026. Medicare Part D costs depend on plan tier placement.
Source: GoodRx 2026, CMS Medicare Part D, FDA Drug Shortage Database
Why Hospitals Charge So Much
When a patient is admitted to a hospital for a condition unrelated to ADHD and continues to receive their prescribed Adderall, the hospital bills the drug at its facility rate rather than the retail pharmacy rate. Hospitals must maintain special controlled-substance dispensing procedures for Schedule II drugs like amphetamines, including locked storage, pharmacist verification, and detailed chain-of-custody logging. This adds real overhead to the actual drug cost, resulting in markups above retail.
Unlike most other inpatient drugs, Adderall's price exposure in a hospital bill is typically modest because patients usually take low unit-count doses (one or two tablets per day) and the generic acquisition cost is low. The more common billing issue is whether the hospital will even administer a Schedule II drug during a stay for an unrelated condition: some hospital formularies require a psychiatry consult before continuing an outpatient stimulant. Patients who need to dispute any hospital medication charge can use the CoveredUSA Medical Bill Analyzer to identify line-item errors.
Patient Assistance Programs
Most generic amphetamine manufacturers do not run traditional patient assistance programs because the generic drug is already inexpensive. However, Takeda (which markets brand Adderall XR and Vyvanse) runs programs for patients who cannot afford brand-name stimulants. Discount programs are the primary cost-reduction tool for most patients:
Patient assistance programs for Adderall| Manufacturer program | Cost / Benefit | How to apply |
|---|
| Takeda Help at Hand (brand Adderall XR / Vyvanse) | Free brand medication for uninsured or underinsured; income below ~400% FPL | helpathandpap.com |
| Takeda Co-Pay Assistance (brand Adderall XR / Vyvanse) | Reduces brand co-pay for commercially insured patients | takedapatientsupport.com |
| GoodRx / RxSaver discount coupons (generic) | $17 - $45/month generic IR or XR at most major pharmacies | goodrx.com |
NeedyMeds.org lists additional programs. Generic amphetamine salts are available from multiple manufacturers; coupon prices are typically the lowest-cost option for uninsured patients.
Source: Takeda Help at Hand, NeedyMeds.org, GoodRx 2026
Medicare Part D
Adderall and generic amphetamine salts are Part D drugs, meaning Medicare covers them through prescription drug plans rather than Part B. Coverage depends on your specific plan's formulary. Most Part D plans include generic mixed amphetamine salts IR and XR, typically on Tier 2 (preferred generic) or Tier 3, but prior authorization and quantity limits are common. Plans may require documentation of an ADHD diagnosis from a prescriber before approving coverage.
As of 2026, the Medicare Part D annual out-of-pocket cap is $2,100. Once you have spent $2,100 in true out-of-pocket costs on covered Part D drugs, your plan pays 100% for the rest of the year. For most patients whose Adderall is their primary prescription expense, this cap provides a hard ceiling. Note that Medicare Part D does not extend the $35/month insulin cap to stimulants: there is no special monthly cap for Adderall under current law.
Common Adderall Billing Errors
Adderall is an oral Schedule II controlled substance and is not billed with HCPCS J-codes. Billing errors are less common than with injectable drugs but still occur in the following ways:
- Brand billed when generic was dispensed: if the pharmacy fills with generic amphetamine salts but the claim is submitted as brand Adderall XR, the patient is charged brand-tier cost
- Prior authorization denial billed to patient: if the PA was not obtained but the prescription was dispensed anyway, the full cost may incorrectly land on the patient rather than trigger a plan appeal
- Wrong days-supply submitted (30 vs 90 days): pharmacies sometimes submit a 30-day supply code for a 90-day fill, resulting in incorrect co-pay calculation
- Shortage substitution billing: if a pharmacy substitutes one dose strength for another due to shortage without updating the claim, the claim may be billed at the wrong tier
Frequently Asked Questions
How much does generic Adderall cost without insurance in 2026?
Generic Adderall IR (immediate-release) costs roughly $30 to $100 for a 30-day supply at retail pharmacies without insurance in 2026. Generic Adderall XR (extended-release) runs $50 to $300 depending on dose. With a GoodRx or RxSaver coupon, many pharmacies will fill generic IR for $17 to $45 per month. Brand-name Adderall XR has a list price around $415 but this is rarely what anyone pays.
Is Adderall still in shortage in 2026?
Yes, as of early 2026, the FDA and ASHP still list mixed amphetamine salts IR and XR as in shortage. The shortage started in October 2022. The DEA increased amphetamine production quotas by 25% in late 2025, which has improved availability for some strengths. Doses of 15 mg, 20 mg, 25 mg, and 30 mg remain intermittently unavailable. If you cannot fill your prescription, ask the pharmacist about stock at other locations, request a partial fill, or ask your prescriber about an alternate stimulant.
Does Medicare Part D cover Adderall?
Most Medicare Part D plans cover generic mixed amphetamine salts IR and XR, typically on Tier 2 or Tier 3. Prior authorization is common: your prescriber will need to document your ADHD diagnosis. The 2026 annual Part D out-of-pocket cap is $2,100, after which the plan pays 100%. There is no special monthly cap for stimulants like there is for insulin ($35/month). Check your specific plan's formulary or call your plan's member services to confirm coverage.
Why is there an Adderall shortage and how does it affect price?
Adderall is a Schedule II controlled substance, and the DEA sets annual quotas on how much active amphetamine ingredient manufacturers can produce. When demand surged post-COVID for ADHD treatment, manufacturers hit quota limits. The 2022-2026 shortage created secondary effects: some patients pay higher prices by switching to brand-name products when generics are unavailable, or pay multiple dispensing fees by splitting fills across pharmacies. The DEA raised the 2026 quota but backlog recovery is slow.
What is the cheapest way to get Adderall in 2026?
For most uninsured patients, using a free GoodRx or RxSaver coupon for generic amphetamine salts IR or XR at a Costco, Walmart, or large chain pharmacy is the cheapest option, often $17 to $45 per month. Mark-Cuban Cost Plus Drugs (costplusdrugs.com) also lists generic amphetamine salts at below typical retail prices. For patients with income below 400% of the federal poverty level, Takeda's Help at Hand PAP provides free brand Adderall XR and Vyvanse.
Does Medicaid cover Adderall?
Yes. Medicaid covers amphetamine salts in all 50 states with a typical copay of $1 to $4 per prescription. Most state Medicaid programs require prior authorization for stimulants, which means your doctor must submit documentation of an ADHD diagnosis. If you have low income and are not enrolled in Medicaid, you may qualify. Check eligibility at your state Medicaid agency or through your state marketplace.
Is there a patient assistance program for Adderall?
Takeda runs the Help at Hand program for brand Adderall XR and Vyvanse, providing free medication to uninsured or underinsured patients with income generally below 400% FPL. Most generic amphetamine salts manufacturers do not run traditional PAPs because the generic is already low-cost. For the uninsured, coupon programs (GoodRx, RxSaver) and Cost Plus Drugs are typically more practical than PAP applications for generic versions.
Can the hospital administer Adderall during a stay?
Yes, but hospitals often require a psychiatry consult before continuing an outpatient Schedule II stimulant during an inpatient stay. The drug may not appear on the hospital's formulary, so continuity depends on the facility. If you are admitted, bring your medication bottles and ask your admitting physician to place a pharmacy order. If the hospital cannot administer it, you may need to arrange a temporary break in therapy, which your outpatient prescriber should document.
